← Open Payments lookup

SUSAN GEORGE: Open Payments

NPI 1760176515 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,945 in 203 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $1,374 · 2025 $2,945

Food & beverage: $2,945
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.12$299
Supernus Pharmaceuticals, Inc.25$282
Alkermes, Inc.13$268
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)24$255
Collegium Pharmaceutical, Inc.19$234
Vanda Pharmaceuticals Inc.11$218
Otsuka America Pharmaceutical, Inc.19$214
Axsome Therapeutics, Inc.12$208
ABBVIE INC.15$189
Takeda Pharmaceuticals U.S.A., Inc.15$146

Products named: INGREZZA, Qelbree, ARISTADA, CAPLYTA, Jornay PM, REXULTI, Auvelity, VRAYLAR.

Industry payments across FL — which companies pay providers there.